Table of Contents 1 Market Overview 1.1 Diabetes Therapeutics and Diagnostics Introduction 1.2 Market Analysis by Type 1.2.1 Insulin 1.2.2 Insulin Delivery 1.2.3 Oral Hypoglycemic Drugs 1.2.4 Diagnosis And Monitoring 1.2.5 Others 1.3 Market Analysis by Applications 1.3.1 Type 1 Diabetes 1.3.2 Type 2 Diabetes 1.3.3 Gestational Diabetes 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 77 Elektronika Kft. 2.1.1 Business Overview 2.1.1.1 77 Elektronika Kft. Description 2.1.1.2 77 Elektronika Kft. Headquarter, Main Business and Finance Overview 2.1.2 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product Introduction 2.1.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.1.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.1 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.3.2 Global 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Market Share in 2017 2.2 A. Menarini Diagnostics S.R.L 2.2.1 Business Overview 2.2.1.1 A. Menarini Diagnostics S.R.L Description 2.2.1.2 A. Menarini Diagnostics S.R.L Headquarter, Main Business and Finance Overview 2.2.2 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product Introduction 2.2.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.2.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.1 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.3.2 Global A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Market Share in 2017 2.3 Abbott Laboratories 2.3.1 Business Overview 2.3.1.1 Abbott Laboratories Description 2.3.1.2 Abbott Laboratories Headquarter, Main Business and Finance Overview 2.3.2 Abbott Laboratories Diabetes Therapeutics and Diagnostics Product Introduction 2.3.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.3.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.1 Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.3.2 Global Abbott Laboratories Diabetes Therapeutics and Diagnostics Market Share in 2017 2.4 Agamatrix Inc. 2.4.1 Business Overview 2.4.1.1 Agamatrix Inc. Description 2.4.1.2 Agamatrix Inc. Headquarter, Main Business and Finance Overview 2.4.2 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product Introduction 2.4.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.4.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.1 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.3.2 Global Agamatrix Inc. Diabetes Therapeutics and Diagnostics Market Share in 2017 2.5 Animas Corp. 2.5.1 Business Overview 2.5.1.1 Animas Corp. Description 2.5.1.2 Animas Corp. Headquarter, Main Business and Finance Overview 2.5.2 Animas Corp. Diabetes Therapeutics and Diagnostics Product Introduction 2.5.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.5.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.1 Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.3.2 Global Animas Corp. Diabetes Therapeutics and Diagnostics Market Share in 2017 2.6 Ascensia 2.6.1 Business Overview 2.6.1.1 Ascensia Description 2.6.1.2 Ascensia Headquarter, Main Business and Finance Overview 2.6.2 Ascensia Diabetes Therapeutics and Diagnostics Product Introduction 2.6.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.6.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.6.3 Ascensia Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.3.1 Ascensia Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.3.2 Global Ascensia Diabetes Therapeutics and Diagnostics Market Share in 2017 2.7 Becton Dickinson 2.7.1 Business Overview 2.7.1.1 Becton Dickinson Description 2.7.1.2 Becton Dickinson Headquarter, Main Business and Finance Overview 2.7.2 Becton Dickinson Diabetes Therapeutics and Diagnostics Product Introduction 2.7.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.7.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7.3.1 Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7.3.2 Global Becton Dickinson Diabetes Therapeutics and Diagnostics Market Share in 2017 2.8 Debiotech S.A. 2.8.1 Business Overview 2.8.1.1 Debiotech S.A. Description 2.8.1.2 Debiotech S.A. Headquarter, Main Business and Finance Overview 2.8.2 Debiotech S.A. Diabetes Therapeutics and Diagnostics Product Introduction 2.8.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.8.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8.3.1 Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8.3.2 Global Debiotech S.A. Diabetes Therapeutics and Diagnostics Market Share in 2017 2.9 Eli Lilly And Co. 2.9.1 Business Overview 2.9.1.1 Eli Lilly And Co. Description 2.9.1.2 Eli Lilly And Co. Headquarter, Main Business and Finance Overview 2.9.2 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product Introduction 2.9.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.9.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9.3.1 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9.3.2 Global Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Market Share in 2017 2.10 Glaxo Smithkline 2.10.1 Business Overview 2.10.1.1 Glaxo Smithkline Description 2.10.1.2 Glaxo Smithkline Headquarter, Main Business and Finance Overview 2.10.2 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product Introduction 2.10.2.1 Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors 2.10.2.2 Diabetes Therapeutics and Diagnostics Product Information 2.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10.3.1 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10.3.2 Global Glaxo Smithkline Diabetes Therapeutics and Diagnostics Market Share in 2017 2.11 Inlight Solutions Inc. 2.11.1 Business Overview 2.11.2 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product Introduction 2.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Johnson & Johnson 2.12.1 Business Overview 2.12.2 Johnson & Johnson Diabetes Therapeutics and Diagnostics Product Introduction 2.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Lifescan Inc. 2.13.1 Business Overview 2.13.2 Lifescan Inc. Diabetes Therapeutics and Diagnostics Product Introduction 2.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Medtronic 2.14.1 Business Overview 2.14.2 Medtronic Diabetes Therapeutics and Diagnostics Product Introduction 2.14.3 Medtronic Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Merck & Co. 2.15.1 Business Overview 2.15.2 Merck & Co. Diabetes Therapeutics and Diagnostics Product Introduction 2.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Merck KGAA 2.16.1 Business Overview 2.16.2 Merck KGAA Diabetes Therapeutics and Diagnostics Product Introduction 2.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Nipro Corp. 2.17.1 Business Overview 2.17.2 Nipro Corp. Diabetes Therapeutics and Diagnostics Product Introduction 2.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Novartis Pharma Ag 2.18.1 Business Overview 2.18.2 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product Introduction 2.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Novo Nordisk A/S 2.19.1 Business Overview 2.19.2 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product Introduction 2.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 Owen Mumford Ltd. 2.20.1 Business Overview 2.20.2 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product Introduction 2.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 Palco Labs Inc. 2.21.1 Business Overview 2.21.2 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product Introduction 2.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22 Roche 2.22.1 Business Overview 2.22.2 Roche Diabetes Therapeutics and Diagnostics Product Introduction 2.22.3 Roche Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23 Sanofi 2.23.1 Business Overview 2.23.2 Sanofi Diabetes Therapeutics and Diagnostics Product Introduction 2.23.3 Sanofi Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.24 Takeda Pharmaceutical Co. Ltd. 2.24.1 Business Overview 2.24.2 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Product Introduction 2.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.25 Terumo Corp. 2.25.1 Business Overview 2.25.2 Terumo Corp. Diabetes Therapeutics and Diagnostics Product Introduction 2.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Diabetes Therapeutics and Diagnostics Market Competition, by Manufacturer 3.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Manufacturer (2016-2017) 3.3 Global Diabetes Therapeutics and Diagnostics Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Diabetes Therapeutics and Diagnostics Manufacturer Market Share in 2017 3.4.2 Top 5 Diabetes Therapeutics and Diagnostics Manufacturer Market Share in 2017 3.5 Market Competition Trend 4 Global Diabetes Therapeutics and Diagnostics Market Analysis by Regions 4.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Regions 4.1.1 Global Diabetes Therapeutics and Diagnostics Sales by Regions (2013-2018) 4.1.2 Global Diabetes Therapeutics and Diagnostics Revenue by Regions (2013-2018) 4.2 North America Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2013-2018) 4.3 Europe Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2013-2018) 4.5 South America Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2013-2018) 5 North America Diabetes Therapeutics and Diagnostics by Countries, Type, Application and Manufacturers 5.1 North America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries 5.1.1 North America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) 5.1.2 North America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) 5.1.3 United States Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 5.1.4 Canada Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 5.1.5 Mexico Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 5.2 North America Diabetes Therapeutics and Diagnostics Sales and Revenue (Value) by Manufacturers (2016-2017) 5.2.1 North America Diabetes Therapeutics and Diagnostics Sales by Manufacturers (2016-2017) 5.2.2 North America Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2016-2017) 5.3 North America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 5.3.1 North America Diabetes Therapeutics and Diagnostics Sales and Sales Share by Type (2013-2018) 5.3.2 North America Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Type (2013-2018) 5.4 North America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Application (2013-2018) 5.4.1 North America Diabetes Therapeutics and Diagnostics Sales and Sales Share by Application (2013-2018) 5.4.2 North America Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Application (2013-2018) 6 Europe Diabetes Therapeutics and Diagnostics by Countries, Type, Application and Manufacturers 6.1 Europe Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries 6.1.1 Europe Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) 6.1.2 Europe Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) 6.1.3 Germany Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 6.1.4 UK Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 6.1.5 France Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 6.1.6 Russia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 6.1.7 Italy Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 6.2 Europe Diabetes Therapeutics and Diagnostics Sales and Revenue (Value) by Manufacturers (2016-2017) 6.2.1 Europe Diabetes Therapeutics and Diagnostics Sales by Manufacturers (2016-2017) 6.2.2 Europe Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2016-2017) 6.3 Europe Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 6.3.1 Europe Diabetes Therapeutics and Diagnostics Sales and Sales Share by Type (2013-2018) 6.3.2 Europe Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Type (2013-2018) 6.4 Europe Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Application (2013-2018) 6.4.1 Europe Diabetes Therapeutics and Diagnostics Sales and Sales Share by Application (2013-2018) 6.4.2 Europe Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Application (2013-2018) 7 Asia-Pacific Diabetes Therapeutics and Diagnostics by Countries, Type, Application and Manufacturers 7.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) 7.1.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) 7.1.3 China Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 7.1.4 Japan Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 7.1.5 Korea Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 7.1.6 India Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 7.1.7 Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 7.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Revenue (Value) by Manufacturers (2016-2017) 7.2.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Manufacturers (2016-2017) 7.2.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2016-2017) 7.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 7.3.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Sales Share by Type (2013-2018) 7.3.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Type (2013-2018) 7.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Application (2013-2018) 7.4.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Sales Share by Application (2013-2018) 7.4.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Application (2013-2018) 8 South America Diabetes Therapeutics and Diagnostics by Countries, Type, Application and Manufacturers 8.1 South America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries 8.1.1 South America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) 8.1.2 South America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) 8.1.3 Brazil Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 8.1.4 Argentina Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 8.1.5 Colombia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 8.2 South America Diabetes Therapeutics and Diagnostics Sales and Revenue (Value) by Manufacturers (2016-2017) 8.2.1 South America Diabetes Therapeutics and Diagnostics Sales by Manufacturers (2016-2017) 8.2.2 South America Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2016-2017) 8.3 South America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 8.3.1 South America Diabetes Therapeutics and Diagnostics Sales and Sales Share by Type (2013-2018) 8.3.2 South America Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Type (2013-2018) 8.4 South America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Application (2013-2018) 8.4.1 South America Diabetes Therapeutics and Diagnostics Sales and Sales Share by Application (2013-2018) 8.4.2 South America Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Application (2013-2018) 9 Middle East and Africa Diabetes Therapeutics and Diagnostics by Countries, Type, Application and Manufacturers 9.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) 9.1.2 Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) 9.1.3 Saudi Arabia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 9.1.4 UAE Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 9.1.5 Egypt Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 9.1.6 Nigeria Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 9.1.7 South Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) 9.2 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Revenue (Value) by Manufacturers (2016-2017) 9.2.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Manufacturers (2016-2017) 9.2.2 Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2016-2017) 9.3 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 9.3.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Sales Share by Type (2013-2018) 9.3.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Type (2013-2018) 9.4 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Application (2013-2018) 9.4.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Sales Share by Application (2013-2018) 9.4.2 Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Revenue Share by Application (2013-2018) 10 Global Diabetes Therapeutics and Diagnostics Market Segment by Type 10.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018) 10.1.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018) 10.2 Insulin Sales Growth and Price 10.2.1 Global Insulin Sales Growth (2013-2018) 10.2.2 Global Insulin Price (2013-2018) 10.3 Insulin Delivery Sales Growth and Price 10.3.1 Global Insulin Delivery Sales Growth (2013-2018) 10.3.2 Global Insulin Delivery Price (2013-2018) 10.4 Oral Hypoglycemic Drugs Sales Growth and Price 10.4.1 Global Oral Hypoglycemic Drugs Sales Growth (2013-2018) 10.4.2 Global Oral Hypoglycemic Drugs Price (2013-2018) 10.5 Diagnosis And Monitoring Sales Growth and Price 10.5.1 Global Diagnosis And Monitoring Sales Growth (2013-2018) 10.5.2 Global Diagnosis And Monitoring Price (2013-2018) 10.6 Others Sales Growth and Price 10.6.1 Global Others Sales Growth (2013-2018) 10.6.2 Global Others Price (2013-2018) 11 Global Diabetes Therapeutics and Diagnostics Market Segment by Application 11.1 Global Diabetes Therapeutics and Diagnostics Sales Market Share by Application (2013-2018) 11.2 Type 1 Diabetes Sales Growth (2013-2018) 11.3 Type 2 Diabetes Sales Growth (2013-2018) 11.4 Gestational Diabetes Sales Growth (2013-2018) 11.5 Others Sales Growth (2013-2018) 12 Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023) 12.2 Diabetes Therapeutics and Diagnostics Market Forecast by Regions (2018-2023) 12.2.1 North America Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.2.2 Europe Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.2.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.2.4 South America Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.2.5 Middle East and Africa Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) 12.3 Diabetes Therapeutics and Diagnostics Market Forecast by Type (2018-2023) 12.3.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type (2018-2023) 12.3.2 Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023) 12.4 Diabetes Therapeutics and Diagnostics Market Forecast by Application (2018-2023) 12.4.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Application (2018-2023) 12.4.2 Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Diabetes Therapeutics and Diagnostics Picture Table Product Specifications of Diabetes Therapeutics and Diagnostics Figure Global Diabetes Therapeutics and Diagnostics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million) Figure Global Diabetes Therapeutics and Diagnostics CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales) Figure Global Sales Market Share of Diabetes Therapeutics and Diagnostics by Types in 2017 Figure Insulin Picture Table Major Manufacturers of Insulin Figure Insulin Delivery Picture Table Major Manufacturers of Insulin Delivery Figure Oral Hypoglycemic Drugs Picture Table Major Manufacturers of Oral Hypoglycemic Drugs Figure Diagnosis And Monitoring Picture Table Major Manufacturers of Diagnosis And Monitoring Figure Others Picture Table Major Manufacturers of Others Figure Diabetes Therapeutics and Diagnostics Sales Market Share by Applications in 2017 Figure Type 1 Diabetes Picture Figure Type 2 Diabetes Picture Figure Gestational Diabetes Picture Figure Others Picture Figure United States Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Canada Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Germany Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure France Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure UK Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Russia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Italy Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure China Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Japan Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Korea Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure India Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023) Table 77 Elektronika Kft. Headquarter, Established, Main Business and Finance Overview (2017) Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table A. Menarini Diagnostics S.R.L Headquarter, Established, Main Business and Finance Overview (2017) Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Abbott Laboratories Headquarter, Established, Main Business and Finance Overview (2017) Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Product Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Agamatrix Inc. Headquarter, Established, Main Business and Finance Overview (2017) Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Animas Corp. Headquarter, Established, Main Business and Finance Overview (2017) Table Animas Corp. Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Animas Corp. Diabetes Therapeutics and Diagnostics Product Table Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Animas Corp. Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Animas Corp. Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Ascensia Headquarter, Established, Main Business and Finance Overview (2017) Table Ascensia Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Ascensia Diabetes Therapeutics and Diagnostics Product Table Ascensia Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Ascensia Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Ascensia Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Becton Dickinson Headquarter, Established, Main Business and Finance Overview (2017) Table Becton Dickinson Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Becton Dickinson Diabetes Therapeutics and Diagnostics Product Table Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Becton Dickinson Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Debiotech S.A. Headquarter, Established, Main Business and Finance Overview (2017) Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Product Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Eli Lilly And Co. Headquarter, Established, Main Business and Finance Overview (2017) Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Glaxo Smithkline Headquarter, Established, Main Business and Finance Overview (2017) Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Production Bases, Sales Regions and Major Competitors Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Figure Global Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales Market Share in 2017 Figure Global Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue Market Share in 2017 Table Inlight Solutions Inc. Table Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Table Johnson & Johnson Table Johnson & Johnson Diabetes Therapeutics and Diagnostics Table Lifescan Inc. Table Lifescan Inc. Diabetes Therapeutics and Diagnostics Table Medtronic Table Medtronic Diabetes Therapeutics and Diagnostics Table Merck & Co. Table Merck & Co. Diabetes Therapeutics and Diagnostics Table Merck KGAA Table Merck KGAA Diabetes Therapeutics and Diagnostics Table Nipro Corp. Table Nipro Corp. Diabetes Therapeutics and Diagnostics Table Novartis Pharma Ag Table Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Table Novo Nordisk A/S Table Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Table Owen Mumford Ltd. Table Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Table Palco Labs Inc. Table Palco Labs Inc. Diabetes Therapeutics and Diagnostics Table Roche Table Roche Diabetes Therapeutics and Diagnostics Table Sanofi Table Sanofi Diabetes Therapeutics and Diagnostics Table Takeda Pharmaceutical Co. Ltd. Table Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Table Terumo Corp. Table Terumo Corp. Diabetes Therapeutics and Diagnostics Table Global Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table Global Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table Global Diabetes Therapeutics and Diagnostics Price by Manufacturer (2016-2017) Figure Top 3 Diabetes Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Diabetes Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2017 Figure Global Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Global Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales by Regions (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales Market Share by Regions (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Revenue by Regions (2013-2018) Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Regions in 2013 Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Regions in 2017 Figure North America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure North America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Figure Europe Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Europe Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Figure South America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure South America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Figure North America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018) Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2013 Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017 Table North America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018) Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2013 Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017 Figure United States Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Canada Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Mexico Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table North America Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table North America Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Revenue by Application (2013-2018) Table North America Diabetes Therapeutics and Diagnostics Revenue Share by Application (2013-2018) Figure Europe Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2016 Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017 Figure Germany Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure UK Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure France Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Russia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Italy Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure Europe Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure Europe Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table Europe Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table Europe Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Revenue by Application (2013-2018) Table Europe Diabetes Therapeutics and Diagnostics Revenue Share by Application (2013-2018) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Countries 2017 Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries 2017 Figure China Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Japan Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Korea Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure India Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Application (2013-2018) Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Share by Application (2013-2018) Figure South America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018) Figure South America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017 Table South America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018) Figure South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017 Figure Brazil Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Argentina Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Colombia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure South America Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure South America Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table South America Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table South America Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Revenue by Application (2013-2018) Table South America Diabetes Therapeutics and Diagnostics Revenue Share by Application (2013-2018) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017 Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2013 Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure UAE Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Egypt Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure Nigeria Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Figure South Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016 Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017 Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017) Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016 Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017 Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Application (2013-2018) Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Share by Application (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018) Figure Global Insulin Sales Growth (2013-2018) Figure Global Insulin Price (2013-2018) Figure Global Insulin Delivery Sales Growth (2013-2018) Figure Global Insulin Delivery Price (2013-2018) Figure Global Oral Hypoglycemic Drugs Sales Growth (2013-2018) Figure Global Oral Hypoglycemic Drugs Price (2013-2018) Figure Global Diagnosis And Monitoring Sales Growth (2013-2018) Figure Global Diagnosis And Monitoring Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018) Table Global Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018) Figure Global Type 1 Diabetes Sales Growth (2013-2018) Figure Global Type 2 Diabetes Sales Growth (2013-2018) Figure Global Gestational Diabetes Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Regions (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Regions (2018-2023) Figure North America Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) Figure Europe Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) Figure Asia-Pacific Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) Figure South America Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) Figure Middle East and Africa Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Application (2018-2023) Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

77 Elektronika Kft. A. Menarini Diagnostics S.R.L Abbott Laboratories Agamatrix Inc. Animas Corp. Ascensia Becton Dickinson Debiotech S.A. Eli Lilly And Co. Glaxo Smithkline Inlight Solutions Inc. Johnson & Johnson Lifescan Inc. Medtronic Merck & Co. Merck KGAA Nipro Corp. Novartis Pharma Ag Novo Nordisk A/S Owen Mumford Ltd. Palco Labs Inc. Roche Sanofi Takeda Pharmaceutical Co. Ltd. Terumo Corp.